Form 4: Sangamo Therapeutics CEO Sandy Macrae Reports Share Disposition for Tax Obligations
SEC Form 4
CEO Sandy Macrae disposed of shares to cover tax obligations related to vested restricted stock units (RSUs).
Summary
- On January 22, 2025, Sandy Macrae, the CEO and a director of Sangamo Therapeutics, disposed of 412,584 shares of common stock to cover tax obligations related to the vesting of restricted stock units.
- The shares were surrendered at a price of $1.15 per share, which was the Issuer's closing stock price on January 22, 2025.
- Following the transaction, Macrae beneficially owns 2,095,999 shares of Sangamo Therapeutics.
- These shares include those from previous RSU grants that are vesting in installments through January 22, 2026, February 25, 2025 and February 24, 2026.
Sentiment
Score: 5
Explanation: This is a neutral filing related to tax obligations. It doesn't inherently indicate positive or negative sentiment.
Future Outlook
The document mentions future vesting dates for existing RSU grants, indicating continued equity-based compensation for the reporting person.
Industry Context
Form 4 filings are routine disclosures for corporate insiders and are a normal part of corporate governance. This filing indicates that the CEO is managing their equity compensation and tax obligations.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the disposition of shares by an insider, but it is related to tax obligations and not a discretionary sale.
Key Dates
| Date | Description |
|---|---|
| February 25, 2022 | Date of RSU grant that will vest in one final installment on February 25, 2025. |
| February 24, 2023 | Date of RSU grant that will vest in successive equal quarterly installments through February 24, 2026. |
| January 22, 2024 | Date of RSU grant, 587,416 shares resulting from the January 22, 2025 vesting installment, and the remaining 1,000,000 shares will vest in successive equal quarterly installments through January 22, 2026. |
| January 22, 2025 | Date of transaction where 412,584 shares were disposed of to cover tax obligations; vesting installment of RSU grant. |
| February 25, 2025 | Date of final vesting installment of February 25, 2022 RSU grant. |
| February 24, 2026 | Date through which February 24, 2023 RSU grant will vest in successive equal quarterly installments. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.